FutureMeds - Birmingham

Public research footprint of FutureMeds - Birmingham, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Obesity · Overweight and/or Obesity · Chronic Kidney Disease (CKD) · Atherosclerosis Cardiovascular Disease

Recently updated registry entries

NCT07613294 — A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With… (Recruiting)
NCT07064473 — EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin… (Recruiting)
NCT07400653 — A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at FutureMeds - Birmingham?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.